이오탈라믹산-d3
Iothalamic Acid
데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
기본 정보
- CAS
928623-31-8- 표준 SMILES
CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I- InChIKey
UXIGWFXRQKWHHA-UHFFFAOYSA-N- 분자식
- C11.H9.I3.N2.O4
- 평균 분자량
- 613.91 g/mol
개요
Iotalamic acid is an organic molecular entity.
이름 및 식별자
- 우선 이름
- Iothalamic Acid
- IUPAC
- 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid
- 현지명
- 이오탈라믹산-d3
- 영어명
- IothalaMic Acid-d3
- 분자식
- C11H9I3N2O4
- 분자량
- 613.91357
이름 및 동의어
iotalamic acidIOTHALAMIC ACID2276-90-63-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acidAcido iotalamicoAcide iotalamiqueAcidum iotalamicumMI-21616CHD79MIXNSC-759891DTXSID5023164Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-
이름 더 보기
이오탈라믹산-d3IothalaMic Acid-d3[2H3]-Iothalamic Acid2,4,6-triiodo-3-(methylcarbamoyl)-5-[(2,2,2-trideuterioacetyl)amino]benzoic acid
Acid, IotalamicAngioConrayAngio ConrayAcid, IothalamicAcid, MethalamicIothalamate, SodiumRefChem:56855DTXCID903164
데이터베이스 식별자
- CAS
928623-31-8- ChEMBL
CHEMBL1201300- ChEBI
CHEBI:31713- UNII
- 16CHD79MIX
- EC Number
- 218-897-4
- Nikkaji
- J7.384I
물성
구조 계산 물성보충 중
- XLogP
- 1.9
- 극성 표면적
- 95.5 Ų
- 수소 결합 공여자 수
- 3
- 수소 결합 수용자 수
- 4
- 회전 가능 결합 수
- 3
- 무거운 원자 수
- 20
- 형식 전하
- 0
- 복잡도
- 420
실험 및 물리화학적 성질
Drugs
Pharmaceuticals -> Listed in ZINC15
Pharmaceuticals
LogP-1.15
Human DrugsBreast Feeding; Lactation; Milk, Human; Diagnostic Media; Contrast Agents
물리화학적 성질
- 녹는점
- 287 °C · >287°C (dec.)
- 저장 조건
- Refrigerator
- 용해도
- DMSO(약간 용해됨), 메탄올(약간 용해됨, 초음파처리)
- 물리적 상태
- 고체
- 색상
- 흰색에서 황백색까지
화학적 성질
Off-White Solid
안전 및 규제
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
GHS 분류
GHS ClassificationNot Classified
유해성 정보
Regulatory InformationStatus: Active Update: 27-10-2014 https://echa.europa.eu/registration-dossier/-/registered-dossier/12157
Other Safety InformationIMAP assessments - Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-[(methylamino)carbonyl]-: Environment tier I assessment
Hazard Classes and CategoriesNot Classified
안전 및 보호
Protective Action Criteria (PAC)
70 [mg/m3]
770 [mg/m3]
4600 [mg/m3]
독성 정보
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
화학 및 산업
약리 정보
ATC Code
V - Various
QV - Various
Protein BindingIothalamate salts are poorly bound to serum albumin.
Biological Half-LifeIn patients with normal renal function, the alpha and beta half-lives of Conray were approximately 10 and 90 minutes, respectively.
FDA Pharmacological Classification
16CHD79MIX
IOTHALAMIC ACID
Established Pharmacologic Class [EPC] - Radiographic Contrast Agent
Mechanisms of Action [MoA] - X-Ray Contrast Activity
Iothalamic acid is a Radiographic Contrast Agent. The mechanism of action of iothalamic acid is as a X-Ray Contrast Activity.
MeSH Pharmacological ClassificationSubstances used to allow enhanced visualization of tissues.
Absorption, Distribution and Excretion
Renal accumulation is sufficiently rapid that maximum radiographic density in the calyces and pelves occurs, in most instances, about 3 to 8 minutes after injection. In patients with impaired renal function, diagnostic opacification frequently is achieved only after prolonged periods.
Following intravascular injection, Conray is rapidly transported through the circulatory system to the kidneys and is excreted unchanged in the urine by glomerular filtration. The liver and small intestine provide the major alternate route of excretion. In patients with severe renal impairment, the excretion of this contrast medium through the gallbladder and into the small intestine sharply increases.
용도 및 제조
UsesUse (kg; approx.) in Germany (2009): >500
응용 분야
관련 반응
0건
현재 필터 조건에 해당하는 반응 기록이 없습니다.
화합물 노트
불러오는 중…